Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Aronow

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 25, 2022
A Systematic Comparison of Dose Distributions Delivered in <sup>125</sup>I Plaque Brachytherapy and Proton Radiation Therapy for Ocular MelanomaAlexei V Trofimov, Mary E Aronow, Evangelos S Gragoudas, et al.
Ophthalmology. Retina|May 19, 2022
A Comparison of Treatment Outcomes after Standard Dose (70 Gy) versus Reduced Dose (50 Gy) Proton Radiation in Patients with Uveal MelanomaAnne Marie Lane, Monica M Oxenreiter, Mustafa Hashmi, et al.
Ocular Immunology and Inflammation|February 24, 2022
Clinical Outcomes in Vitrectomized versus Non-vitrectomized Eyes in Patients with Primary Vitreoretinal LymphomaPaulina Liberman, Jasmine H Francis, Karnika Mehrotra, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2023
In Reply to Elmali and YaziciAlexei V Trofimov, Mary E Aronow, Marc R Bussière, et al.
Investigative Ophthalmology & Visual Science|April 19, 2012
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism arrayArun D Singh, Mary E Aronow, Yang Sun, et al.
Retina (Philadelphia, Pa.)|May 17, 2019
VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic AspectsMary E Aronow, Henry E Wiley, Alain Gaudric, et al.
Ophthalmic Genetics|April 29, 2020
Juvenile cataract in association with tuberous sclerosis complexA L Geffrey, K R Geenen, E Abati, et al.
Progress in Retinal and Eye Research|October 20, 2025
Clinical histopathology and pathogenesis of macular telangiectasia type 2Dimitrios P Ntentakis, Anastasia Maria Ntentaki, Eleni Delavogia, et al.
Ophthalmology. Retina|January 10, 2022
Treatment of Aggressive Retinal Astrocytic Hamartoma with Oral Mechanistic Target of Rapamycin InhibitionFrances Wu, Mark P McGarrey, Kennedy R Geenen, et al.
Cancer Genetics|December 3, 2014
Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognosticationEugen C Minca, Raymond R Tubbs, Bryce P Portier, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|July 25, 2022
A Systematic Comparison of Dose Distributions Delivered in <sup>125</sup>I Plaque Brachytherapy and Proton Radiation Therapy for Ocular MelanomaAlexei V Trofimov, Mary E Aronow, Evangelos S Gragoudas, et al.
Ophthalmology. Retina|May 19, 2022
A Comparison of Treatment Outcomes after Standard Dose (70 Gy) versus Reduced Dose (50 Gy) Proton Radiation in Patients with Uveal MelanomaAnne Marie Lane, Monica M Oxenreiter, Mustafa Hashmi, et al.
Ocular Immunology and Inflammation|February 24, 2022
Clinical Outcomes in Vitrectomized versus Non-vitrectomized Eyes in Patients with Primary Vitreoretinal LymphomaPaulina Liberman, Jasmine H Francis, Karnika Mehrotra, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2023
In Reply to Elmali and YaziciAlexei V Trofimov, Mary E Aronow, Marc R Bussière, et al.
Investigative Ophthalmology & Visual Science|April 19, 2012
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism arrayArun D Singh, Mary E Aronow, Yang Sun, et al.
Retina (Philadelphia, Pa.)|May 17, 2019
VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic AspectsMary E Aronow, Henry E Wiley, Alain Gaudric, et al.
Ophthalmic Genetics|April 29, 2020
Juvenile cataract in association with tuberous sclerosis complexA L Geffrey, K R Geenen, E Abati, et al.
Progress in Retinal and Eye Research|October 20, 2025
Clinical histopathology and pathogenesis of macular telangiectasia type 2Dimitrios P Ntentakis, Anastasia Maria Ntentaki, Eleni Delavogia, et al.
Ophthalmology. Retina|January 10, 2022
Treatment of Aggressive Retinal Astrocytic Hamartoma with Oral Mechanistic Target of Rapamycin InhibitionFrances Wu, Mark P McGarrey, Kennedy R Geenen, et al.
Cancer Genetics|December 3, 2014
Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognosticationEugen C Minca, Raymond R Tubbs, Bryce P Portier, et al.
Pageof 6